Analogous oligo-acyl-lysines with distinct antibacterial mechanisms

被引:60
作者
Rotem, Shahar
Radzishevsky, Inna S.
Bourdetsky, Dmitry
Navon-Venezia, Shiri [2 ]
Carmeli, Yehuda [2 ]
Mor, Amram [1 ]
机构
[1] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, LAPI, Haifa, Israel
[2] Tel Aviv Sourasky Med Ctr, Dept Epidemiol, Tel Aviv, Israel
关键词
host defense peptides; peptidomimetics; mechanism of action; intracellular targets;
D O I
10.1096/fj.07-105015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bactericidal properties were recently shown to emerge from hydrophobicity and charge buildup in oligo-acyl-lysine (OAK) peptide mimetics. Toward understanding the attributes that govern the activity of this novel antimicrobial system, we compared the functional and mechanistic properties of a known octamer and a newly generated hexamer analog. The data provide strong evidence for multiple similarities that included high tissue stability, low hemolysis, large-spectrum antibacterial activity in vitro, and the ability to prevent Escherichia coli-induced mortality in vivo. Despite these similarities, however, the octamer mode of action involved membrane disruption, unlike the hexamer, which acted predominantly through inhibition of DNA functions with characteristically slower bactericidal kinetics. Collectively, the data support the view that the analogous OAKs induced bacterial death by distinct mechanisms and further suggest that relatively minor differences in the sequence of host defense peptides are responsible for selecting one mechanism over another, possibly in conjunction with differential binding affinities to the external and/or cytoplasmic membrane.
引用
收藏
页码:2652 / 2661
页数:10
相关论文
共 50 条
  • [1] Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity
    Avrahami, D
    Shai, Y
    [J]. BIOCHEMISTRY, 2002, 41 (07) : 2254 - 2263
  • [2] MECHANISMS OF ACTION ON ESCHERICHIA-COLI OF CECROPIN-P1 AND PR-39, 2 ANTIBACTERIAL PEPTIDES FROM PIG INTESTINE
    BOMAN, HG
    AGERBERTH, B
    BOMAN, A
    [J]. INFECTION AND IMMUNITY, 1993, 61 (07) : 2978 - 2984
  • [3] Cationic antimicrobial peptides - Issues for potential clinical use
    Bradshaw, JP
    [J]. BIODRUGS, 2003, 17 (04) : 233 - 240
  • [4] COCIANCICH S, 1993, J BIOL CHEM, V268, P19239
  • [5] SOLID-PHASE PEPTIDE-SYNTHESIS UTILIZING 9-FLUORENYLMETHOXYCARBONYL AMINO-ACIDS
    FIELDS, GB
    NOBLE, RL
    [J]. INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1990, 35 (03): : 161 - 214
  • [6] Frimodt-Moller N., 1999, Handbook of animal model of infection, P127, DOI DOI 10.1016/B978-012775390-4/50153-6
  • [7] Analysis of membrane-binding properties of dermaseptin analogues: Relationships between binding and cytotoxicity
    Gaidukov, L
    Fish, A
    Mor, A
    [J]. BIOCHEMISTRY, 2003, 42 (44) : 12866 - 12874
  • [8] Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
    Goldman, MJ
    Anderson, GM
    Stolzenberg, ED
    Kari, UP
    Zasloff, M
    Wilson, JM
    [J]. CELL, 1997, 88 (04) : 553 - 560
  • [9] A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs
    Gordon, YJ
    Romanowski, EG
    McDermott, AM
    [J]. CURRENT EYE RESEARCH, 2005, 30 (07) : 505 - 515
  • [10] Peptide antibiotics
    Hancock, REW
    [J]. LANCET, 1997, 349 (9049) : 418 - 422